Frank E. Thomas
2016
In 2016, Frank E. Thomas earned a total compensation of $1.8M as President and Chief Operating Officer at AMAG Pharmaceuticals, a 5% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $372,180 |
|---|---|
| Option Awards | $438,488 |
| Salary | $510,877 |
| Stock Awards | $428,060 |
| Other | $7,950 |
| Total | $1,757,555 |
Thomas received $510.9K in salary, accounting for 29% of the total pay in 2016.
Thomas also received $372.2K in non-equity incentive plan, $438.5K in option awards, $428.1K in stock awards and $8K in other compensation.
Rankings
In 2016, Frank E. Thomas' compensation ranked 5,489th out of 14,075 executives tracked by ExecPay. In other words, Thomas earned more than 61.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,489 out of 14,075 | 61st |
Division Manufacturing | 1,973 out of 5,486 | 64th |
Major group Chemicals And Allied Products | 626 out of 1,900 | 67th |
Industry group Drugs | 468 out of 1,543 | 70th |
Industry Pharmaceutical Preparations | 371 out of 1,173 | 68th |
Source: SEC filing on April 20, 2017.
Thomas' colleagues
We found five more compensation records of executives who worked with Frank E. Thomas at AMAG Pharmaceuticals in 2016.
2016
William Heiden
AMAG Pharmaceuticals
Chief Executive Officer
2016
Nicholas Grund
AMAG Pharmaceuticals
Chief Commercial Officer
2016
Edward Myles
AMAG Pharmaceuticals
Chief Financial Officer
2016
Julie Krop
AMAG Pharmaceuticals
Chief Medical Officer
2016
Joseph Vittiglio
AMAG Pharmaceuticals